Neuropace Inc (NPCE) Directors and Executive Officers

Officers & Directors

Rebecca Kuhn
Chief Financial Officer and Vice President, Finance and Administration - (Principal Financial Officer and Principal Accounting Officer)

Uri Geiger
Director

Joseph S. Lacob
Director

Joel Becker
Director, President and Chief Executive Officer - (Principal Executive Officer)

Renee Ryan
Director

San Jose, California

Rakhi Kumar
Director

Frank Fischer
Director

Lisa Andrade
Director ,

Neuropace Inc currently has 209 employees.

News about Neuropace Inc Key Personnel

NeuroPace’s New Leadership Amidst Financial Struggles: A Strategic Move or a Hail Mary

In a significant shift in its corporate strategy, NeuroPace Inc. a leader in the development of innovative neurostimulation treatments, has recently appointed an experienced people leader as its Vice President of Human Resources. This move comes at a crucial time for the company, which has seen its shares plummet by 21.8% over the past three months, reflecting growing anxieties among investors about its financial health and market viability.The appointment of the new human resources leader signals a potential pivot for NeuroPace, which has been grappling with a staggering cumulative net loss of $33 million over the past 12 months, culminating in a negative return on assets (ROA) of -33.27% as of the second q...

NeuroPace Reports Promising Revenue Growth for Q4 2023 and Full Year 2023, Despite Recent Financial Setbacks

NeuroPace, a leading medical technology company specializing in neuromodulation therapies, announced its preliminary unaudited revenue for the fourth quarter and full year 2023, along with some important business updates. The company expects its revenue for Q4 2023 to fall between $17.5 million and $18.0 million, while the full-year revenue is projected to be in the range of $64.9 million and $65.4 million. These figures indicate a steady growth for NeuroPace, despite some recent financial challenges.
During the 12 months leading up to the third quarter of 2023, NeuroPace Inc recorded a cumulative net loss of $-38 million, resulting in a negative return on investment (ROI) of -40.24%. This news come...